Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK3 | O14649 | 12/20 | 0.93 |
| ▸ | KCNK9 | Q9NPC2 | 8/20 | 0.93 |
| ▸ | MEN1 | O00255 | 5/20 | 0.93 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.93 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.93 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.93 |
| ▸ | POLB | P06746 | 1/20 | 0.84 |
| ▸ | RAB9A | P51151 | 3/20 | 0.73 |
| ▸ | NPC1 | O15118 | 2/20 | 0.73 |
| ▸ | TP53 | P04637 | 1/20 | 0.73 |
| ▸ | HTT | P42858 | 1/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.71 |
| ▸ | THRB | P10828 | 1/20 | 0.71 |
| ▸ | NT5E | P21589 | 1/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.70 |
| ▸ | GAA | P10253 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 1/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16681527 | 0.93 | KCNK3 (0.87) | KCNK3KCNK9MEN1KMT2AKCNH2 | |
| SCHEMBL21377679 | 0.91 | KCNK3 (0.84) | KCNK3KCNK9MEN1KMT2AKCNH2 | |
| SCHEMBL30608967 | 0.91 | KCNK3 (0.87) | KCNK3KCNK9MEN1KMT2AKCNH2 | |
| SCHEMBL259666 | 0.91 | KCNK3 (0.87) | KCNK3KCNK9MEN1KMT2AKCNH2 | |
| SCHEMBL259468 | 0.91 | KCNK3 (0.87) | KCNK3KCNK9MEN1KMT2AKCNH2 | |
| SCHEMBL29434800 | 0.91 | KCNK3 (0.87) | KCNK3KCNK9MEN1KMT2AKCNH2 | |
| SCHEMBL16675166 | 0.91 | KCNK3 (0.89) | KCNK3KCNK9MEN1KMT2AKCNH2 | |
| SCHEMBL2908619 | 0.91 | MEN1 (0.89) | KCNK3KCNK9MEN1KMT2AKCNH2 | |
| SCHEMBL11669212 | 0.90 | KCNK3 (0.81) | KCNK3KCNK9MEN1KMT2AKCNH2 | |
| SCHEMBL10806300 | 0.90 | MEN1 (0.81) | KCNK3KCNK9MEN1KMT2AKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118420484-B | Method for preparing amide compounds | 四川大学 | 2024-08-30 | — | — | CN | disclosed |
| CN-118420484-A | Method for preparing amide compounds | 四川大学 | 2024-08-02 | — | — | CN | disclosed |
| EP-3312160-A1 | HEPATITIS B ANTIVIRAL AGENTS | Novira Therapeutics Inc. (US) | 2018-04-25 | — | — | EP | disclosed |
| EP-1773786-B1 | FIVE-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-04-26 | — | — | EP | disclosed |
| US-20160082699-A1 | RESIN LAYER-ATTACHED SUPPORTING SUBSTRATE AND METHOD FOR PRODUCING SAME, GLASS LAMINATE AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING ELECTRONIC DEVICE | ASAHI GLASS COMPANY, LIMITED (JP) | 2016-03-24 | — | — | US | disclosed |
| US-20160075110-A1 | FLEXIBLE SUBSTRATE AND METHOD FOR PRODUCING SAME, GLASS LAMINATE AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING ELECTRONIC DEVICE | ASAHI GLASS COMPANY, LIMITED (JP) | 2016-03-17 | — | — | US | disclosed |
| US-8357210-B2 | Disazo acid dyes | CLARIANT FINANCE (BVI) LIMITED (VG) | 2013-01-22 | — | — | US | disclosed |
| EP-2027213-B1 | DISAZO ACID DYES | CLARIANT FINANCE BVI LTD (VG) | 2012-11-21 | — | — | EP | disclosed |
| US-20110203058-A1 | Disazo Acid Dyes | CLARIANT FINANCE (BVI) LIMITED (VG) | 2011-08-25 | — | — | US | disclosed |
| US-7754196-B2 | Cosmetic composition comprising fiber | L'OREAL (FR) | 2010-07-13 | — | — | US | disclosed |
| US-20090126128-A1 | Disazo Acid Dyes | CLARIANT FINANCE (BVI) LIMITED (VG) | 2009-05-21 | — | — | US | disclosed |
| US-20090036420-A1 | BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-02-05 | — | — | US | disclosed |
| WO-2009016088-A1 | THE USE OF BENZAMIDE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-02-05 | — | — | WO | disclosed |
| US-20090036420-A1 | BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-02-05 | — | — | US | disclosed |
| US-20090036420-A1 | BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-02-05 | — | — | US | disclosed |
| US-20080008932-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2008-01-10 | — | — | US | disclosed |
| US-20080008932-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2008-01-10 | — | — | US | disclosed |
| US-7157548-B2 | Crosslinked sulfonated polyimide films | HANYANG HAK WON CO., LTD. (KR) | 2007-01-02 | — | — | US | disclosed |
| US-7157548-B2 | Crosslinked sulfonated polyimide films | HANYANG HAK WON CO., LTD. (KR) | 2007-01-02 | — | — | US | disclosed |
| US-3988364-A | ANTITUSSIVE AGENTS | TOYO JOZO KABUSHIKI KAISHA (JA) | 1976-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036420-A1 | BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS | GABBR1, GABBR2, CHRM2 | KCNK3 1019/4885KCNK9 1229/4885MEN1 1233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.